Profiel
William R.
Shanahan worked as a Director of Clinical Research at Pfizer Central Research from 1990 to 1994, as an Associate Director and Director of Clinical Research at Searle Research & Development from 1986 to 1989, as a Vice President of Drug Development at Ionis Pharmaceuticals, Inc. from 1994 to 2000, as a Chief Medical Officer at Tanox, Inc. from 2000 to 2004, as a Chief Medical Officer and Senior Vice President at Arena Pharmaceuticals, Inc. from 2011 to 2016, and as a Chief Medical Officer at Anthera Pharmaceuticals, Inc. from 2016 to 2018.
Prior to his career in the pharmaceutical industry, he was an Associate Professor at the University of Connecticut.
Shanahan received his undergraduate degree from Dartmouth College, his graduate degree from Loyola University of Chicago, and his doctorate from the University of California, San Francisco.
Eerdere bekende functies van William R. Shanahan
Bedrijven | Functie | Einde |
---|---|---|
ANTHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 15-04-2018 |
ARENA PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 13-06-2016 |
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Chief Tech/Sci/R&D Officer | 01-03-2004 |
IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-08-2000 |
Pfizer Central Research | Chief Tech/Sci/R&D Officer | 01-01-1994 |
Opleiding van William R. Shanahan
Dartmouth College | Undergraduate Degree |
Loyola University of Chicago | Graduate Degree |
The University of California, San Francisco | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
IONIS PHARMACEUTICALS, INC. | Health Technology |
ANTHERA PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Pfizer Central Research | |
Searle Research & Development |